RecallRadar

FDA Drug recall D-0269-2024

Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury,…

On 2024-01-31 the FDA classified a Class II recall of Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury,… by Sun Pharmaceutical Industries, citing CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0269-2024
ClassificationClass II
Statuscompleted
Initiated2024-01-18
Published2024-01-31
Last updated2026-09-13 11:52 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-613-81.

Reason

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Identifiers

ndc47335-539-83
ndc47335-539-81
ndc47335-539-88
ndc47335-539-08
ndc47335-539-18
ndc47335-614-83
ndc47335-614-81
ndc47335-614-88
ndc47335-614-18
ndc47335-613-83
ndc47335-613-81
ndc47335-613-88
ndc47335-613-08
ndc47335-613-18
code_infoLot #: DNE0788A Exp. 07/31/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0269-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.